Apic Bio, Inc. announced it raised $42.3 Million in an amended filing from an offering of $46.1 Million

Nov 12, 2020•almost 5 years ago

Amount Raised

$42.3 Million

CambridgeBiotechnology

Company Information

Company

Apic Bio, Inc.

Location

35 CAMBRIDGEPORT DRIVE, SUITE 350

Cambridge, Maryland, United States

About

Apic Bio, Inc., is a pre-clinical stage gene therapy company leveraging its proprietary platform to advance therapies to treat rare diseases with complex mechanisms.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech